IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,991 | -15.5% | 7,164,209 | -6.6% | 0.16% | -11.1% |
| Q2 2023 | $81,612 | +2.4% | 7,670,309 | +1.2% | 0.18% | +0.6% |
| Q1 2023 | $79,717 | -18.8% | 7,577,709 | -4.4% | 0.18% | -17.5% |
| Q4 2022 | $98,208 | -99.9% | 7,926,397 | +0.2% | 0.22% | +12.4% |
| Q3 2022 | $81,991,000 | -4.9% | 7,914,220 | +5.8% | 0.19% | +3.8% |
| Q2 2022 | $86,235,000 | -7.5% | 7,479,157 | +1.0% | 0.19% | +8.8% |
| Q1 2022 | $93,184,000 | +6.5% | 7,407,330 | -1.3% | 0.17% | +10.3% |
| Q4 2021 | $87,536,000 | -14.2% | 7,507,406 | -3.9% | 0.16% | -15.8% |
| Q3 2021 | $102,027,000 | +81.6% | 7,812,227 | +79.0% | 0.18% | +93.7% |
| Q2 2021 | $56,167,000 | +415.8% | 4,364,227 | +348.1% | 0.10% | +400.0% |
| Q1 2021 | $10,889,000 | – | 973,999 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |